No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:142869400-142872800 |
Enhancers |
Dnd41 |
blood
|
2 |
chr6:142869600-142873200 |
Enhancers |
Primary T helper naive cells fromperipheralblood |
blood
|
3 |
chr6:142871000-142872600 |
Enhancers |
iPS-15b Cell Line |
embryonic stem cell
|
4 |
chr6:142871000-142873200 |
Enhancers |
HSMMtube |
muscle
|
5 |
chr6:142871400-142872600 |
Enhancers |
HUES48 Cell Line |
embryonic stem cell
|
6 |
chr6:142871400-142872800 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
7 |
chr6:142871400-142873000 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
8 |
chr6:142871400-142873200 |
Enhancers |
Fetal Stomach |
stomach
|
9 |
chr6:142871400-142873200 |
Enhancers |
HSMM |
muscle
|
10 |
chr6:142871400-142873400 |
Enhancers |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
11 |
chr6:142871600-142873200 |
Enhancers |
Primary T killer naive cells fromperipheralblood |
blood
|
12 |
chr6:142871600-142873600 |
Enhancers |
Fetal Lung |
lung
|
13 |
chr6:142871800-142872800 |
Enhancers |
Primary T helper cells PMA-I stimulated |
--
|
14 |
chr6:142871800-142873000 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
15 |
chr6:142871800-142873000 |
Enhancers |
Fetal Muscle Leg |
muscle
|
16 |
chr6:142871800-142873000 |
Enhancers |
Fetal Thymus |
thymus
|
17 |
chr6:142872000-142873200 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
18 |
chr6:142872000-142873600 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
19 |
chr6:142872200-142872800 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
20 |
chr6:142872200-142872800 |
Weak transcription |
Primary T killer memory cells from peripheral blood |
blood
|
21 |
chr6:142872200-142873200 |
Flanking Active TSS |
HMEC |
breast
|
22 |
chr6:142872200-142873600 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
23 |
chr6:142872400-142872600 |
Flanking Active TSS |
Muscle Satellite Cultured Cells |
--
|
24 |
chr6:142872400-142872800 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
25 |
chr6:142872400-142872800 |
Enhancers |
Esophagus |
oesophagus
|
26 |
chr6:142872400-142873000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
27 |
chr6:142872400-142873000 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
28 |
chr6:142872400-142873000 |
Flanking Active TSS |
Primary T cells from cord blood |
blood
|
29 |
chr6:142872400-142873000 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
30 |
chr6:142872400-142873000 |
Enhancers |
NH-A |
brain
|
31 |
chr6:142872400-142873000 |
Bivalent Enhancer |
Osteobl |
bone
|
32 |
chr6:142872400-142873200 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
33 |
chr6:142872400-142873200 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
34 |
chr6:142872400-142873200 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
35 |
chr6:142872400-142873200 |
Flanking Active TSS |
NHEK |
skin
|